Effect of P-gp Inhibition, OATP-inhibition and Food on the Kinetics of a Single Oral Dose BI 685509 in Healthy Male Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 27 May 2017
At a glance
- Drugs BI 685509 (Primary) ; Itraconazole; Rifampicin
- Indications Kidney disorders
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 22 May 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Apr 2017 Status changed from not yet recruiting to recruiting.
- 19 Apr 2017 New trial record